Peninsula biotech hits top of IPO goals, raises $144M

The first of two IPOs expected from South San Francisco biotechs is the fourth from the Bay Area's life science sector this year.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.